KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
4.110
-0.060 (-1.44%)
At close: Jun 6, 2025, 4:00 PM
4.140
+0.030 (0.73%)
After-hours: Jun 6, 2025, 4:00 PM EDT

KALA BIO Statistics

Total Valuation

KALA BIO has a market cap or net worth of $26.52 million. The enterprise value is $17.03 million.

Market Cap 26.52M
Enterprise Value 17.03M

Important Dates

The last earnings date was Wednesday, May 14, 2025, before market open.

Earnings Date May 14, 2025
Ex-Dividend Date n/a

Share Statistics

KALA BIO has 6.45 million shares outstanding. The number of shares has increased by 78.73% in one year.

Current Share Class 6.45M
Shares Outstanding 6.45M
Shares Change (YoY) +78.73%
Shares Change (QoQ) +35.17%
Owned by Insiders (%) 3.86%
Owned by Institutions (%) 30.13%
Float 3.80M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 4.71
P/TBV Ratio 4.71
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.99, with a Debt / Equity ratio of 5.67.

Current Ratio 1.99
Quick Ratio 1.84
Debt / Equity 5.67
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -7.25

Financial Efficiency

Return on equity (ROE) is -576.46% and return on invested capital (ROIC) is -60.45%.

Return on Equity (ROE) -576.46%
Return on Assets (ROA) -48.51%
Return on Invested Capital (ROIC) -60.45%
Return on Capital Employed (ROCE) -155.51%
Revenue Per Employee n/a
Profits Per Employee -$938,184
Employee Count 38
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -39.82% in the last 52 weeks. The beta is -1.98, so KALA BIO's price volatility has been lower than the market average.

Beta (5Y) -1.98
52-Week Price Change -39.82%
50-Day Moving Average 3.88
200-Day Moving Average 6.01
Relative Strength Index (RSI) 55.51
Average Volume (20 Days) 42,052

Short Selling Information

The latest short interest is 286,860, so 4.45% of the outstanding shares have been sold short.

Short Interest 286,860
Short Previous Month 404,588
Short % of Shares Out 4.45%
Short % of Float 7.55%
Short Ratio (days to cover) 3.24

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -39.31M
Pretax Income -38.72M
Net Income -35.65M
EBITDA -39.05M
EBIT -39.31M
Earnings Per Share (EPS) -$7.62
Full Income Statement

Balance Sheet

The company has $42.22 million in cash and $32.35 million in debt, giving a net cash position of $9.87 million or $1.53 per share.

Cash & Cash Equivalents 42.22M
Total Debt 32.35M
Net Cash 9.87M
Net Cash Per Share $1.53
Equity (Book Value) 5.71M
Book Value Per Share 0.88
Working Capital 22.74M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$27.36 million and capital expenditures -$195,000, giving a free cash flow of -$27.56 million.

Operating Cash Flow -27.36M
Capital Expenditures -195,000
Free Cash Flow -27.56M
FCF Per Share -$4.27
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

KALA BIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -78.73%
Shareholder Yield -78.73%
Earnings Yield -132.50%
FCF Yield -102.42%

Analyst Forecast

The average price target for KALA BIO is $14.00, which is 240.63% higher than the current price. The consensus rating is "Strong Buy".

Price Target $14.00
Price Target Difference 240.63%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on October 21, 2022. It was a reverse split with a ratio of 0.02:1.

Last Split Date Oct 21, 2022
Split Type Reverse
Split Ratio 0.02:1

Scores

Altman Z-Score n/a
Piotroski F-Score 2